Iovance Biotherapeutics IOVA Earnings Call Transcripts

NASDAQ IOVA
$8.09 +0.01 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST
8 earnings calls on file for Iovance Biotherapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Iovance Biotherapeutics Q3 2026 Earnings Call

Nov 5, 2026 4,774 words · 21 min read
  • Jen SaundersSenior Director, Investor Relations and Corporate Communications
  • Fred VogtInterim Chief Executive Officer and President
  • Corleen RocheChief Financial Officer
  • Dan KirbyChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Iovance Biotherapeutics Earnings Call Transcripts

Calls8
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 8 Iovance Biotherapeutics transcripts Register to get access to Iovance Biotherapeutics’s earnings call transcripts.